<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Caspian Journal of Internal Medicine</title>
<title_fa></title_fa>
<short_title>Caspian J Intern Med</short_title>
<subject>Medical Sciences</subject>
<web_url>http://caspjim.com</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-6164</journal_id_issn>
<journal_id_issn_online>2008-6172</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.22088/cjim</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<volume>13</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Effect of atorvastatin 1% mouthwash in the prevention of radiotherapy induced mucositis: A pilot study</title>
	<subject_fa>Oncology</subject_fa>
	<subject>Oncology</subject>
	<content_type_fa>Short Communication</content_type_fa>
	<content_type>Short Communication</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;line-height:14pt&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color:blue&quot;&gt;Background&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt;&lt;span style=&quot;color:blue&quot;&gt;:&lt;/span&gt;&lt;/i&gt; Oral mucositis is a troublesome symptom for people who receive radiotherapy and chemotherapy and it is a dose-dependent factor. Atorvastatin is a HMG-CoA reductase inhibitors and various studies have proven its anti-inflammatory effects. The goal of this study was to evaluate atorvastatin 1% mouthwash effects in prevention of radiotherapy-induced mucositis.&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:14pt&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color:blue&quot;&gt;Methods:&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; Atorvastatin 1% suspension was prepared for mouthwash in this randomized, double-blind clinical trial. Thirty patients randomly received atorvastatin or placebo mouthwash. They had to gargle 5cc of mouthwash, 3 times per day during radiotherapy. The severity and pain of mucositis was evaluated every week, during their treatment.&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:14pt&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color:blue&quot;&gt;Results:&lt;/span&gt;&lt;/i&gt;&lt;/b&gt; The severity of mucositis between the two study groups was significant every four weeks (p&lt;0.05) and the percentage of patients with more severe mucositis was less in the atorvastatin group. It is found that the pain intensity was lower after 3 and 4 weeks in atorvastatin group.&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color:blue&quot;&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:14pt&quot;&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color:blue&quot;&gt;Conclusion&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;i&gt;&lt;span style=&quot;color:blue&quot;&gt;:&lt;/span&gt;&lt;/i&gt; These findings indicated that atorvastatin mouthwash showed a significant activity in relieving of radiotherapy-induced oral mucositis and pain.&lt;b&gt;&lt;i&gt;&lt;span style=&quot;color:#0033cc&quot;&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Atorvastatin, Mouthwash, Oral mucositis, Radiotherapy</keyword>
	<start_page>800</start_page>
	<end_page>804</end_page>
	<web_url>http://caspjim.com/browse.php?a_code=A-10-1516-3&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Shahram</first_name>
	<middle_name></middle_name>
	<last_name>Ala</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sh204ala@gmail.com</email>
	<code>100319475328460039912</code>
	<orcid>100319475328460039912</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of clinical pharmacy, Faculty of pharmacy, Mazandaran University of medical science, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Majid</first_name>
	<middle_name></middle_name>
	<last_name>Saeedi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>majsaeedi@gmail.com</email>
	<code>100319475328460039913</code>
	<orcid>100319475328460039913</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmaceutical Sciences, Faculty of pharmacy, Mazandaran University of medical science, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Arash</first_name>
	<middle_name></middle_name>
	<last_name>Ghasemi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>dr_arash_ghasemi@yahoo.com</email>
	<code>100319475328460039914</code>
	<orcid>100319475328460039914</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of radiology and radiation oncology, Faculty of medicine, Mazandaran University of medical science, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Melika</first_name>
	<middle_name></middle_name>
	<last_name>Namdari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Namdarimelika@gmail.com</email>
	<code>100319475328460039915</code>
	<orcid>100319475328460039915</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Student Research Committee, Faculty of pharmacy, Mazandaran University of medical science, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Neda</first_name>
	<middle_name></middle_name>
	<last_name>Koulaeinejad</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>nd.koulaei@gmail.com</email>
	<code>100319475328460039916</code>
	<orcid>100319475328460039916</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
